Elevance Health (NYSE: ELV) is continuing to expand its home-based service line – and seeing the benefits of doing so. Carelon, Elevance’s health care services arm, saw its Q3 operating revenue increase by $4.5 billion year-over-year, according to the company’s third quarter results. One driver of this growth is its acquisitions in home health services, as well as pharmacy services acquisitions, CarelonRx growth and the scaling of Carelon Services’ risk-based solutions. The company is seeking to expand its value-based arrangements as it scales its home-based services offerings, according to Gail K. Boudreaux, Elevance’s president and CEO.
Read the full article: Home Health Acquisitions Fuel Carelon’s 33% Jump in Operating Revenue //
Source: https://homehealthcarenews.com/2025/10/home-health-acquisitions-fuel-carelons-33-jump-in-operating-revenue/